TRCT
MR

Tower Research Capital (TRC)’s MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A MR Stock Holding History

Tower Research Capital (TRC)’s Portfolio MR Stock Details MR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-100
Closed -$3K – 5142
2014
Q1 		$3K Sell
100
-2,370
-96% -$83K ﹤0.01% 3760
2013
Q4 		$90K Buy
2,470
+2,172
+729% +$84.4K 0.02% 930
2013
Q3 		$12K Buy
298
+242
+432% +$9.75K ﹤0.01% 3116
2013
Q2 		$2K Buy
+56
New +$2.21K ﹤0.01% 3584

Other funds holding MR

Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
CBOA
Commonwealth Bank of Australia Sydney, NSW, Australia $231M AUM
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
GAM
Genesis Asset Managers Guernsey, Channel Islands, United Kingdom $3.53B AUM 1.54% 1-Year Est. Return
PP
Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
BCIM
Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return

Tower Research Capital (TRC)'s MR Position: Q2 2014 in Review

Tower Research Capital (TRC) sold out of MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A (MR) in Q2 2014, closing a stake of 100 shares — an estimated $3K sold.

Tower Research Capital (TRC) first reported a position in MR in Q2 2013 and held it in 4 quarters. The position peaked at $90K in Q4 2013. 131 funds tracked by Wall St. Rank hold MR as of Q2 2014.

  • Tower Research Capital (TRC) reported no remaining MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A position as of Q2 2014 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 100 MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A shares in Q2 2014, an estimated $3K.
  • Tower Research Capital (TRC) first reported a position in MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A in Q2 2013 and held it in 4 quarters.
  • Tower Research Capital (TRC)'s MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A position peaked at $90K in Q4 2013.
  • 131 funds tracked by Wall St. Rank held MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A as of Q2 2014.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2014, filed 14 Aug 2014.